Deals
Johnson & Johnson to buy private drug developer for $1.75 billion
Johnson & Johnson (JNJ.N) agreed to pay $1.75 billion in cash to buy privately held Alios BioPharma Inc, which is developing a drug for a common respiratory viral infection in children for which there is no approved treatment.
SRR Advises on Sale of Engineered Polymers Corp.
Stout Risius Ross, Inc. (SRR) announced today that its client, Engineered Polymers Corp. ("EPC"), has been acquired by Imperial Plastics, Incorporated ("Imperial"), a portfolio company of Goldner Hawn Johnson & Morrison Incorporated ("GHJM"). SRR served as exclusive financial advisor to EPC in connection with this transaction.
News Corp to buy real estate website operator Move for $950 mln
Rupert Murdoch's News Corp (NWSA.O) said it would buy Move Inc (MOVE.O), the owner of property websites such as realtor.com, for about $950 million to expand its digital marketing business.
New U.S. tax rules may lead Medtronic to redo inversion deal
U.S. medical device maker Medtronic Inc is likely to try to renegotiate the structure and terms of its $42.9 billion deal to buy Ireland's Covidien Plc in response to new U.S. tax rules, according to people familiar with the situation.




